FDA notifications. Generic lamivudine tentatively approved.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D006801:Humans; D007223:Infant; D019259:Lamivudine / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine